Pregabalin Elimination in Dialysis Patients with Severe Renal Impairment
In a patient with GFR of 8 requiring dialysis, approximately 90% of a single 50mg pregabalin dose would be removed from renal excretion, necessitating significant dose adjustment and careful timing around dialysis sessions. 1
Pregabalin Pharmacokinetics in Severe Renal Impairment
- Pregabalin is primarily eliminated through renal excretion with approximately 90% of the drug excreted unchanged in the urine 1
- Total and renal pregabalin clearance are directly proportional to creatinine clearance (approximately 56-58% proportional to CrCl) 1
- In patients with severe renal impairment (GFR <15 mL/min), pregabalin clearance is dramatically reduced, leading to drug accumulation and increased risk of toxicity 1, 2
Hemodialysis Effects on Pregabalin
- Pregabalin is highly dialyzable with approximately 50% removed during a standard 4-hour hemodialysis session 3
- Hemodialysis clearance of pregabalin has been measured at 88.8 mL/min in case reports 4
- The drug's properties that make it amenable to removal by hemodialysis include:
- Low molecular weight (159.23 Da)
- Relatively low volume of distribution (0.5 L/kg)
- Lack of plasma protein binding 4
Dosing Recommendations for Dialysis Patients
- For patients with CrCl <15 mL/min (including those on hemodialysis), the pregabalin dose should be significantly reduced compared to patients with normal renal function 1
- Daily doses should be reduced by approximately 50% for each 50% decrease in CrCl below 60 mL/min 1
- Supplemental doses may be required after each hemodialysis session to maintain therapeutic levels 1
- Medication administration should be scheduled after hemodialysis to avoid premature removal of the drug 5
Risks of Inappropriate Dosing in Renal Failure
- Pregabalin toxicity in renal failure can manifest as:
- Abrupt discontinuation of pregabalin in patients with renal impairment can lead to withdrawal symptoms including seizures 7
Clinical Implications
- For a patient with GFR of 8 requiring dialysis, a single 50mg dose would have significantly altered pharmacokinetics:
- Regular medication reconciliation at each transition of care is essential to prevent inappropriate dosing in dialysis patients 5